Section R66-2-13 - Processing of Cannabis and Cannabis Product(1) A cannabis processing facility shall process, manufacture, package, and label cannabis and cannabis product in accordance with 21 CFR 111, "Current Good Manufacturing, Packaging, Labeling, or Holding Operation for Dietary Supplements."(2) Cannabis and cannabis product shall be packaged in child-resistant packaging in accordance with 16 CFR 1700.(3) A cannabis processing facility shall package cannabis or cannabis product in accordance with this rule and Section 4-41a-602 before transportation to a medical cannabis pharmacy.(4) Any container or packaging containing cannabis or cannabis product shall protect the product from contamination and may not impart any toxic or deleterious substance to the cannabis or cannabis product.(5) Cannabis cultivation byproduct shall either be:(a) chemically or physically processed to produce a cannabis concentrate for incorporation into cannabis derivative product; or(b) destroyed according to Section 4-41a-405.(6) Cannabis concentrate and product produced by cannabis processing facilities shall be tested pursuant to Rule R68-29.(7) If a cannabis product contains artificially derived cannabinoids they shall be isolated to a purity of greater than 95%, as required by Subsection 4-41a-603(3).(8) A cannabis product may vary in the cannabis product's labeled cannabinoid profile by up to 10% of the indicated amount of a given cannabinoid, by weight.Utah Admin. Code R66-2-13
Adopted by Utah State Bulletin Number 2024-10, effective 5/13/2024